DV
Dividend Vision

ARCT — Arctus Therapeutics Holdings Inc.

Arctus Therapeutics Holdings Inc. (ARCT)

Total return is -84.4% over the past 13.2 years, 571.0 points behind SPY at 486.6%. Its deepest 1-year drawdown was 76.1%.

ARCT is an equity stock that operates in the therapeutics sector. As a single-stock holding rather than a diversified fund, it does not generate a distribution yield and carries no published expense ratio typical of ETFs. This holding appeals primarily to investors seeking direct exposure to a specific therapeutic company rather than those pursuing passive dividend income strategies.

ARCT key facts

Asset type
Stock
Asset class
Equity
Inception date
05/22/2013
Last close
$8.23
Market cap
$233,921,840
Average volume
930500.0
Payment date
11/16/2017
Beta
2.271
Payout ratio
0.0
Forward P/E
2.4777
EPS
$-3.33